Items Tagged ‘cutaneous lymphoma’

January 19th, 2015

FDA Grants Fast Track Designation to SGX301 for First-Line Treatment of Cutaneous T-Cell Lymphoma


The U. S. Food and Drug Administration has granted Fast Track designation the synthetic hypericin (SGX301) development program for the first-line treatment of cutaneous T-cell lymphoma. Fast Track designation from the FDA is reserved for drugs that demonstrate the potential to address an unmet medical need for a serious or life-threatening condition. SGX301 previously received […]

View full entry

Tags: cutaneous lymphoma, hypericin, News, Non-Hodgkin's Lymphoma, photodynamic therapy, sgx301, T-Cell Non-Hodgkin's Lymphoma